ALVIN S PARVEN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ALVIN S PARVEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ALVIN S PARVEN. ALVIN S PARVEN is Director in ALEXION PHARMACEUTICALS INC ($ALXN).
Latest Insider Trading Transactions of ALVIN S PARVEN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 16 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 116.78 | 835 | 97,511 | 7,568 | 8.4 K to 7.6 K (-9.94 %) |
May 12 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Grant | A | 0.00 | 2,030 | 0 | 8,403 | 6.4 K to 8.4 K (+31.85 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 96.35 | 3,425 | 329,999 | 0 | |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 85.75 | 3,237 | 277,573 | 0 | |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 49.43 | 5,572 | 275,424 | 0 | |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 26.64 | 7,932 | 211,308 | 0 | |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 141.22 | 22 | 3,107 | 3,880 | 3.9 K to 3.9 K (-0.56 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 140.59 | 117 | 16,449 | 3,902 | 4 K to 3.9 K (-2.91 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 139.49 | 435 | 60,678 | 4,019 | 4.5 K to 4 K (-9.77 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 138.60 | 421 | 58,351 | 4,454 | 4.9 K to 4.5 K (-8.64 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 137.56 | 599 | 82,398 | 4,875 | 5.5 K to 4.9 K (-10.94 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 135.69 | 31 | 4,206 | 5,474 | 5.5 K to 5.5 K (-0.56 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 133.95 | 15 | 2,009 | 5,505 | 5.5 K to 5.5 K (-0.27 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 133.65 | 853 | 114,003 | 5,520 | 6.4 K to 5.5 K (-13.38 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 141.23 | 278 | 39,262 | 6,373 | 6.7 K to 6.4 K (-4.18 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 140.59 | 1,433 | 201,465 | 6,651 | 8.1 K to 6.7 K (-17.73 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 139.49 | 5,350 | 746,272 | 8,084 | 13.4 K to 8.1 K (-39.82 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 138.60 | 5,176 | 717,394 | 13,434 | 18.6 K to 13.4 K (-27.81 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 137.56 | 7,375 | 1,014,505 | 18,610 | 26 K to 18.6 K (-28.38 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 135.70 | 369 | 50,073 | 25,985 | 26.4 K to 26 K (-1.40 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 133.95 | 185 | 24,781 | 26,354 | 26.5 K to 26.4 K (-0.70 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 96.35 | 3,425 | 329,999 | 26,539 | 23.1 K to 26.5 K (+14.82 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 85.75 | 3,237 | 277,573 | 23,114 | 19.9 K to 23.1 K (+16.29 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 49.43 | 5,572 | 275,424 | 19,877 | 14.3 K to 19.9 K (+38.95 %) |
Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 26.64 | 7,932 | 211,308 | 14,305 | 6.4 K to 14.3 K (+124.46 %) |
Aug 24 2016 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 18.01 | 15,000 | 270,150 | 0 | |
Aug 24 2016 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 136.53 | 15,000 | 2,047,950 | 6,373 | 21.4 K to 6.4 K (-70.18 %) |
Aug 24 2016 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 18.01 | 15,000 | 270,150 | 21,373 | 6.4 K to 21.4 K (+235.37 %) |
Aug 24 2016 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 135.51 | 700 | 94,857 | 6,373 | 7.1 K to 6.4 K (-9.90 %) |
May 13 2016 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 138.86 | 2,294 | 318,545 | 2,294 | |
May 13 2016 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Grant | A | 0.00 | 835 | 0 | 7,073 | 6.2 K to 7.1 K (+13.39 %) |
Nov 04 2015 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 178.73 | 895 | 159,963 | 4,645 | 5.5 K to 4.6 K (-16.16 %) |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 155.01 | 2,343 | 363,188 | 2,343 | |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Grant | A | 0.00 | 700 | 0 | 5,540 | 4.8 K to 5.5 K (+14.46 %) |
Nov 13 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 18.01 | 15,000 | 270,150 | 15,000 | |
Nov 13 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 195.66 | 15,000 | 2,934,900 | 4,840 | 19.8 K to 4.8 K (-75.60 %) |
Nov 13 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 18.01 | 15,000 | 270,150 | 19,840 | 4.8 K to 19.8 K (+309.92 %) |
May 15 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 16.83 | 12,276 | 206,605 | 0 | |
May 15 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 160.78 | 12,276 | 1,973,735 | 4,840 | 17.1 K to 4.8 K (-71.72 %) |
May 15 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 16.83 | 12,276 | 206,605 | 17,116 | 4.8 K to 17.1 K (+253.64 %) |
May 07 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 159.70 | 2,785 | 444,765 | 2,785 | |
Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Grant | A | 0.00 | 895 | 0 | 5,735 | 4.8 K to 5.7 K (+18.49 %) |
Feb 13 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 174.06 | 2,471 | 430,102 | 4,840 | 7.3 K to 4.8 K (-33.80 %) |
Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | P | 84.95 | 140 | 11,893 | 7,451 | 7.3 K to 7.5 K (+1.91 %) |
May 09 2013 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 96.35 | 3,425 | 329,999 | 3,425 | |
Mar 12 2013 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 92.00 | 3,115 | 286,580 | 7,311 | 10.4 K to 7.3 K (-29.88 %) |
Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Grant | A | 0.00 | 2,471 | 0 | 11,195 | 8.7 K to 11.2 K (+28.32 %) |
Nov 21 2012 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 10.84 | 30,000 | 325,200 | 0 | |
Nov 21 2012 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 92.16 | 1,413 | 130,222 | 7,311 | 8.7 K to 7.3 K (-16.20 %) |
Nov 21 2012 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 91.51 | 19,281 | 1,764,404 | 8,724 | 28 K to 8.7 K (-68.85 %) |
Nov 21 2012 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 90.74 | 9,306 | 844,426 | 28,005 | 37.3 K to 28 K (-24.94 %) |
Nov 21 2012 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 10.84 | 30,000 | 325,200 | 37,311 | 7.3 K to 37.3 K (+410.34 %) |
Jun 08 2012 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 8.18 | 30,000 | 245,400 | 0 | |
Jun 08 2012 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 91.01 | 30,000 | 2,730,300 | 7,311 | 37.3 K to 7.3 K (-80.41 %) |
Jun 08 2012 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 8.18 | 30,000 | 245,400 | 37,311 | 7.3 K to 37.3 K (+410.34 %) |
May 09 2012 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 85.75 | 3,237 | 277,573 | 3,237 | |
Feb 23 2012 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 81.51 | 5,450 | 444,230 | 7,311 | 12.8 K to 7.3 K (-42.71 %) |
Feb 06 2012 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 0.00 | 3,115 | 0 | 12,761 | 9.6 K to 12.8 K (+32.29 %) |
Nov 01 2011 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 4.93 | 6,364 | 31,375 | 0 | |
Nov 01 2011 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 68.00 | 6,364 | 432,752 | 9,646 | 16 K to 9.6 K (-39.75 %) |
Nov 01 2011 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 4.93 | 6,364 | 31,375 | 16,010 | 9.6 K to 16 K (+65.98 %) |
May 13 2011 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 98.86 | 2,786 | 275,424 | 2,786 | |
Feb 22 2011 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 92.45 | 3,965 | 366,564 | 4,823 | 8.8 K to 4.8 K (-45.12 %) |
Feb 04 2011 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 0.00 | 2,725 | 0 | 8,788 | 6.1 K to 8.8 K (+44.94 %) |
Nov 12 2010 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | S | 9.87 | 11,818 | 116,644 | 3,182 | |
Nov 12 2010 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 72.32 | 11,818 | 854,678 | 6,063 | 17.9 K to 6.1 K (-66.09 %) |
Nov 12 2010 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 9.87 | 11,818 | 116,644 | 17,881 | 6.1 K to 17.9 K (+194.92 %) |
Sep 02 2010 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 56.72 | 8,000 | 453,760 | 6,063 | 14.1 K to 6.1 K (-56.89 %) |
Sep 02 2010 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 5.37 | 8,000 | 42,960 | 14,063 | 6.1 K to 14.1 K (+131.95 %) |
May 13 2010 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 53.28 | 3,966 | 211,308 | 3,966 | |
Feb 18 2010 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 48.68 | 5,089 | 247,733 | 6,063 | 11.2 K to 6.1 K (-45.63 %) |
Feb 01 2010 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 0.00 | 3,965 | 0 | 11,152 | 7.2 K to 11.2 K (+55.17 %) |
Dec 14 2009 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | S | 11.11 | 15,000 | 166,650 | 0 | |
Dec 14 2009 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | S | 8.53 | 15,000 | 127,950 | 0 | |
Dec 14 2009 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 46.12 | 30,000 | 1,383,600 | 7,187 | 37.2 K to 7.2 K (-80.67 %) |
Dec 14 2009 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 11.11 | 15,000 | 166,650 | 37,187 | 22.2 K to 37.2 K (+67.61 %) |
Dec 14 2009 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 8.53 | 15,000 | 127,950 | 22,187 | 7.2 K to 22.2 K (+208.71 %) |
Jul 28 2009 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | S | 7.79 | 15,000 | 116,850 | 0 | |
Jul 28 2009 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 40.06 | 15,000 | 600,900 | 7,187 | 22.2 K to 7.2 K (-67.61 %) |
Jul 28 2009 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 7.79 | 15,000 | 116,850 | 22,187 | 7.2 K to 22.2 K (+208.71 %) |
May 14 2009 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 33.66 | 6,138 | 206,605 | 6,138 | |
Mar 12 2009 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 32.78 | 4,000 | 131,120 | 7,187 | 11.2 K to 7.2 K (-35.76 %) |
Jan 28 2009 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Grant | A | 0.00 | 5,089 | 0 | 11,187 | 6.1 K to 11.2 K (+83.45 %) |
Aug 07 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 80.50 | 7,500 | 603,750 | 0 | |
Aug 07 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 84.13 | 2,000 | 168,250 | 0 | |
Aug 07 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 91.63 | 9,500 | 870,485 | 3,049 | 12.5 K to 3 K (-75.70 %) |
Aug 07 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 80.50 | 7,500 | 603,750 | 12,549 | 5 K to 12.5 K (+148.54 %) |
Aug 07 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 84.25 | 2,000 | 168,500 | 5,049 | 3 K to 5 K (+65.60 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 21.76 | 6,500 | 141,440 | 0 | |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.68 | 300 | 21,204 | 3,049 | 3.3 K to 3 K (-8.96 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.67 | 200 | 14,134 | 3,349 | 3.5 K to 3.3 K (-5.64 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.70 | 300 | 21,210 | 3,549 | 3.8 K to 3.5 K (-7.79 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.65 | 300 | 21,195 | 3,849 | 4.1 K to 3.8 K (-7.23 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.63 | 500 | 35,315 | 4,149 | 4.6 K to 4.1 K (-10.76 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.61 | 400 | 28,244 | 4,649 | 5 K to 4.6 K (-7.92 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.58 | 100 | 7,058 | 5,049 | 5.1 K to 5 K (-1.94 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.57 | 181 | 12,773 | 5,149 | 5.3 K to 5.1 K (-3.40 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.61 | 300 | 21,183 | 5,330 | 5.6 K to 5.3 K (-5.33 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.57 | 100 | 7,057 | 5,630 | 5.7 K to 5.6 K (-1.75 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.56 | 100 | 7,056 | 5,730 | 5.8 K to 5.7 K (-1.72 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.57 | 200 | 14,114 | 5,830 | 6 K to 5.8 K (-3.32 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.56 | 100 | 7,056 | 6,030 | 6.1 K to 6 K (-1.63 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.57 | 300 | 21,171 | 6,130 | 6.4 K to 6.1 K (-4.67 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.53 | 200 | 14,106 | 6,430 | 6.6 K to 6.4 K (-3.02 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.54 | 100 | 7,054 | 6,630 | 6.7 K to 6.6 K (-1.49 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.53 | 115 | 8,111 | 6,730 | 6.8 K to 6.7 K (-1.68 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.55 | 100 | 7,055 | 6,845 | 6.9 K to 6.8 K (-1.44 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.54 | 100 | 7,054 | 6,945 | 7 K to 6.9 K (-1.42 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.52 | 100 | 7,052 | 7,045 | 7.1 K to 7 K (-1.40 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.50 | 200 | 14,100 | 7,145 | 7.3 K to 7.1 K (-2.72 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.51 | 100 | 7,051 | 7,345 | 7.4 K to 7.3 K (-1.34 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.50 | 700 | 49,350 | 7,445 | 8.1 K to 7.4 K (-8.59 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.50 | 1,000 | 70,500 | 8,145 | 9.1 K to 8.1 K (-10.93 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.50 | 400 | 28,200 | 9,145 | 9.5 K to 9.1 K (-4.19 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 70.50 | 4 | 282 | 9,545 | 9.5 K to 9.5 K (-0.04 %) |
Jun 04 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 21.76 | 6,500 | 141,440 | 9,549 | 3 K to 9.5 K (+213.18 %) |
May 30 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 72.03 | 7,500 | 540,225 | 7,500 | |
Feb 25 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 61.35 | 2,000 | 122,700 | 3,049 | 5 K to 3 K (-39.61 %) |
Jan 17 2008 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Grant | A | 0.00 | 2,000 | 0 | 5,049 | 3 K to 5 K (+65.60 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 21.76 | 1,000 | 21,760 | 6,500 | |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 64.50 | 10,000 | 645,000 | 0 | |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 79.00 | 700 | 55,300 | 3,049 | 3.7 K to 3 K (-18.67 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 79.00 | 700 | 55,300 | 3,749 | 4.4 K to 3.7 K (-15.73 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.99 | 1,714 | 135,389 | 4,449 | 6.2 K to 4.4 K (-27.81 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.99 | 400 | 31,596 | 6,163 | 6.6 K to 6.2 K (-6.09 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.98 | 1,400 | 110,572 | 6,563 | 8 K to 6.6 K (-17.58 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.97 | 686 | 54,173 | 7,963 | 8.6 K to 8 K (-7.93 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.97 | 400 | 31,588 | 8,649 | 9 K to 8.6 K (-4.42 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.96 | 1,100 | 86,856 | 9,049 | 10.1 K to 9 K (-10.84 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.95 | 1,000 | 78,950 | 10,149 | 11.1 K to 10.1 K (-8.97 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.94 | 100 | 7,894 | 11,149 | 11.2 K to 11.1 K (-0.89 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.93 | 500 | 39,465 | 11,249 | 11.7 K to 11.2 K (-4.26 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.92 | 400 | 31,568 | 11,749 | 12.1 K to 11.7 K (-3.29 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.91 | 100 | 7,891 | 12,149 | 12.2 K to 12.1 K (-0.82 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.90 | 200 | 15,780 | 12,249 | 12.4 K to 12.2 K (-1.61 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.88 | 100 | 7,888 | 12,449 | 12.5 K to 12.4 K (-0.80 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.86 | 400 | 31,544 | 12,549 | 12.9 K to 12.5 K (-3.09 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.86 | 100 | 7,886 | 12,949 | 13 K to 12.9 K (-0.77 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.84 | 800 | 63,072 | 13,049 | 13.8 K to 13 K (-5.78 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.82 | 100 | 7,882 | 13,849 | 13.9 K to 13.8 K (-0.72 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | M | 78.81 | 100 | 7,881 | 13,949 | 14 K to 13.9 K (-0.71 %) |
Oct 31 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 78.95 | 11,000 | 868,450 | 14,049 | 3 K to 14 K (+360.77 %) |
May 07 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 43.36 | 7,500 | 325,200 | 7,500 | |
Jan 18 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Grant | A | 0.00 | 2,000 | 0 | 3,049 | 1 K to 3 K (+190.66 %) |
Jan 11 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | D | 39.54 | 100 | 3,954 | 1,049 | 1.1 K to 1 K (-8.70 %) |
Jan 11 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | D | 39.53 | 300 | 11,859 | 1,149 | 1.4 K to 1.1 K (-20.70 %) |
Jan 11 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | D | 39.53 | 100 | 3,953 | 1,449 | 1.5 K to 1.4 K (-6.46 %) |
Jan 11 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | D | 39.54 | 100 | 3,954 | 1,549 | 1.6 K to 1.5 K (-6.06 %) |
Jan 11 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | D | 39.52 | 200 | 7,904 | 1,649 | 1.8 K to 1.6 K (-10.82 %) |
Jan 11 2007 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | D | 39.50 | 100 | 3,950 | 1,849 | 1.9 K to 1.8 K (-5.13 %) |